Susan E. Graf

Insider Reports History

Location
400 Technology Square, 4 Th Floor, Cambridge, MA
Signature
/s/ Nelson Sun, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Susan E. Graf:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Finch Therapeutics Group, Inc. Director Common Stock 5.01K $18.2K $3.64 Jun 9, 2023 Direct
Aardvark Therapeutics, Inc. Director Stock Option (right to buy) 30.5K Jun 11, 2025 Direct
CG Oncology, Inc. Director Director Stock Option (right to buy) 24.2K Jun 5, 2025 Direct
CG Oncology, Inc. Director Stock Option (Right to Buy) 15.6K Oct 4, 2024 Direct
Finch Therapeutics Group, Inc. Director Stock Option (right to buy) 10K Jun 8, 2023 Direct

Insider Reports Filed by Susan E. Graf

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AARD Aardvark Therapeutics, Inc. Jun 11, 2025 1 $0 4 Jun 13, 2025 Director
CGON CG Oncology, Inc. Jun 5, 2025 1 $0 4 Jun 6, 2025 Director
AARD Aardvark Therapeutics, Inc. Feb 12, 2025 0 $0 3 Feb 12, 2025 Director
CGON CG Oncology, Inc. Oct 4, 2024 1 $0 4 Oct 7, 2024 Director
CGON CG Oncology, Inc. Jan 24, 2024 0 $0 3 Jan 24, 2024 Director
FNCH Finch Therapeutics Group, Inc. Jun 8, 2023 2 $1.35K 4 Jun 9, 2023 Director
FNCH Finch Therapeutics Group, Inc. Jun 13, 2022 1 $0 4 Jun 15, 2022 Director